Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02818387Unknown
Randomised trial of remifentanil and midazolam in general anesthesia (3 arms), sponsored by Gangnam Severance Hospital. Primary endpoints: Loss of verbal response and eyelash reflex and Loss of eyelash reflex. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02818387.